Frederick Mohr
Keine laufenden Positionen mehr
Karriereverlauf von Frederick Mohr
Ehemalige bekannte Positionen von Frederick Mohr
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ZS PHARMA INC | Direktor/Vorstandsmitglied | 17.12.2015 | - |
Bristol-Myers Squibb Holdings Ltd.
 Bristol-Myers Squibb Holdings Ltd. MiscellaneousMiscellaneous Part of Bristol Myers Squibb Co., Bristol-Myers Squibb Holdings Ltd. is a holding British company. The company is based in Uxbridge, UK. | Corporate Officer/Principal | - | - |
| ASTRAZENECA PLC | Compliance Officer | - | - |
| SIO GENE THERAPIES INC. | General Counsel | 06.06.2017 | - |
Ausbildung von Frederick Mohr
| Yale University | Undergraduate Degree |
| University of Virginia School of Law | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Vereinigtes Königreich | 3 |
Operativ
| General Counsel | 1 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Miscellaneous | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
Bristol-Myers Squibb Holdings Ltd.
Bristol-Myers Squibb Holdings Ltd. MiscellaneousMiscellaneous Part of Bristol Myers Squibb Co., Bristol-Myers Squibb Holdings Ltd. is a holding British company. The company is based in Uxbridge, UK. | Miscellaneous |
ZS Pharma, Inc.
 ZS Pharma, Inc. Pharmaceuticals: MajorHealth Technology ZS Pharma, Inc. engages in the development of development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases. It develops treatment of hyperkalemia. It also focuses on clinical development, novel technology, and clinical trials. The company was founded by Alvaro F. Guillem and Donald Jeffrey Keyser on February 5, 2008 and is headquartered in San Mateo, CA. | Health Technology |
- Börse
- Insiders
- Frederick Mohr
- Erfahrung
